Barrier Therapeutics, Inc. (NASDAQ: BTRX), a pharmaceutical company developing and commercializing products in the field of dermatology, today announced that Al Altomari, Chief Operating Officer, is scheduled to present to the investment community at the FTN Midwest Health Care Conference.
